Drug Shortage Report for DUKORAL
| Report ID | 257524 |
| Drug Identification Number | 02247208 |
| Brand name | DUKORAL |
| Common or Proper name | test |
| Company Name | VALNEVA SWEDEN AB |
| Market Status | MARKETED |
| Active Ingredient(s) | RECOMBINANT CHOLERA TOXIN B SUBUNIT VIBRIO CHOLERAE OGAWA 50 CLASSICAL BIOTYPE, HEAT INACTIVATED VIBRIO CHOLERAE INABA 6973 EL TOR BIOTYPE, FORMALIN INACTIVATED VIBRIO CHOLERAE OGAWA 50 CLASSICAL BIOTYPE, FORMALIN INACTIVATED VIBRIO CHOLERAE INABA 48 CLASSICAL BIOTYPE, HEAT INACTIVATED |
| Strength(s) | 1MG 31250000000CELLS 31250000000CELLS 31250000000CELLS 31250000000CELLS |
| Dosage form(s) | SUSPENSION |
| Route of administration | ORAL ORAL |
| Packaging size | 10ml |
| ATC code | J07AE |
| ATC description | BACTERIAL VACCINES |
| Reason for shortage | Shortage of an active ingredient. |
| Anticipated start date | 2023-02-02 |
| Actual start date | |
| Estimated end date | 2025-04-06 |
| Actual end date | |
| Shortage status | Actual shortage |
| Updated date | 2025-10-08 |
| Company comments | tst |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | GUNNAR ASPLUNDS ALLÉ 16 STOCKHOLM, -- SWEDEN 10521 |
| Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v2 | 2025-10-08 | French | Compare |
| v1 | 2025-10-08 | English | Compare |
Showing 1 to 2 of 2